Demographic profile and outcome analysis of pediatric intensive care patients

E Volakli1, M Sdougka1, M Tamiolaki1

  • 1Pediatric Intensive Care Unit, Hippokratio General Hospital, Thessaloniki, Greece.

Hippokratia
|January 7, 2014
PubMed

Insights

This study analyzed pediatric intensive care unit (PICU) patients in Greece, finding that while the demographic profile matched other studies, the case mix and disease severity differed. Key mortality predictors included high PRISM III-24 scores and inotropic use.

Area of Science:

  • Pediatric Intensive Care
  • Critical Care Medicine
  • Epidemiology

Background:

  • Pediatric intensive care unit (PICU) patient demographics and outcomes can exhibit significant variability.
  • Understanding these variations is crucial for optimizing patient care and resource allocation.
  • This study aimed to characterize the demographic profile and outcomes of patients within a Greek PICU setting.

Purpose of the Study:

  • To analyze the demographic profile of patients admitted to a Greek PICU.
  • To identify key factors influencing patient outcomes, including mortality.
  • To compare the findings with existing literature on PICU populations.

Main Methods:

  • A prospective observational study was conducted.
  • Data collected included patient demographics, comorbidities, diagnoses, severity scores (PRISM III-24, GCS, ISS), procedures, treatments, mechanical ventilation (MV) use, and length of stay (LOS).
  • Statistical analyses involved t-tests, Mann-Whitney U, Kruskal-Wallis, chi-squared tests, and Cox regression.

Main Results:

  • 300 patients (196 boys/104 girls) were studied, with respiratory failure, head trauma, and seizures as primary diagnoses.
  • The actual PICU mortality rate was 9.7%, which was lower than predicted (11.16%).
  • Independent predictors of mortality identified through Cox regression were a high Pediatric Risk of Mortality (PRISM III-24) score and inotropic use.

Conclusions:

  • The demographic profile of the Greek PICU cohort was similar to other studies, but significant differences in case mix and disease severity were observed.
  • The observed mortality rate of 9.7% was relatively high but better than predicted, aligning with the population's characteristics.
  • Factors such as inotropic use and PRISM III-24 score are critical for predicting mortality in this PICU population.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
996
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627